Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-089191
Filing Date
2024-08-14
Accepted
2024-08-14 06:18:15
Documents
6
Effectiveness Date
2024-08-14

Document Format Files

Seq Description Document Type Size
1 S-8 tm2420550-1_s8.htm S-8 54295
2 EXHIBIT 5.1 tm2420550d1_ex5-1.htm EX-5.1 12151
3 EXHIBIT 10.1 tm2420550d1_ex10-1.htm EX-10.1 65024
4 EXHIBIT 23.1 tm2420550d1_ex23-1.htm EX-23.1 1815
5 EX-FILING FEES tm2420550d1_ex-filingfees.htm EX-FILING FEES 10760
6 GRAPHIC image_001.jpg GRAPHIC 2632
  Complete submission text file 0001104659-24-089191.txt   149088
Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281534 | Film No.: 241203972
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)